ResearcherSecond Affiliated Hospital of Chongqing Medical UniversityActive in the last 2 years
Bo Ning
Matched on ORCID iD 0000-0002-6006-5696; OpenAlex author ID A5065616079.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3 (first author 0, last author 1)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 6
2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 3
- Fabrication of cercosporin-loaded polydopamine- cloaked mesoporous silica nanoparticles enhanced photothermal-photodynamic and anticancer activity in pancreati… Co-author DOI 10.1007/s10856-026-07007-4↗
- Curcumol inhibits the growth of xenograft-tumors in mice and the biological activities of pancreatic cancer cells by regulating the miR-21-5p/SMAD7 axis. Last author DOI 10.1080/15384101.2022.2046983↗
- Enhanced pentose phosphate pathway activity promotes pancreatic ductal adenocarcinoma progression via activating YAP/MMP1 axis under chronic acidosis. Co-author DOI 10.7150/ijbs.69526↗
Closest collaborators
The 6 strongest of 6 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Jingsheng Hua · 1 shared paper, 2026
- Hongxin Zhang · 1 shared paper, 2026
- Songlin Fang · 1 shared paper, 2022
- Siyuan Chen · 1 shared paper, 2022
- Jin-Wen Song · 1 shared paper, 2022
- Zhihang Zhou · 1 shared paper, 2022
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.